Priority Date: 02.08.12 (US 201261678800P)

PEPTIDE VACCINES BASED ON THE EGFRvIII SEQUENCE FOR THE TREATMENT OF TUMORS

  • Application ID: EP13826053
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Kilburn & Strode LLP is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.08.2012 - Priority Date (US 201261678800P)
  • 06.02.2014 - Publication A2 (WO2014022835)
  • 10.06.2015 - Publication A2 (EP2879705)

IPC Classification